NCT01794793 2024-10-01Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesRECORDATI GROUPPhase 4 Completed337 enrolled 8 charts
NCT00414765 2021-06-08Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic MelanomaNovartisPhase 4 Completed26 enrolled 7 charts